- Report
- June 2024
- 191 Pages
Global
From €3675EUR$3,939USD£3,105GBP
- Report
- April 2024
- 180 Pages
Global
From €4572EUR$4,900USD£3,862GBP
- Report
- October 2023
- 189 Pages
Global
From €4572EUR$4,900USD£3,862GBP
- Report
- July 2024
- 150 Pages
Global
From €3499EUR$3,750USD£2,956GBP
- Report
- January 2024
- 200 Pages
Global
From €3872EUR$4,150USD£3,271GBP
- Report
- December 2023
- 184 Pages
Global
From €2333EUR$2,500USD£1,970GBP
- Report
- March 2024
- 190 Pages
Global
From €3675EUR$3,939USD£3,105GBP
- Report
- April 2024
- 364 Pages
Global
From €5330EUR$5,912USD£4,350GBP
- Report
- February 2024
- 175 Pages
Global
From €4665EUR$5,000USD£3,941GBP
- Report
- March 2024
- 135 Pages
Global
From €3638EUR$3,899USD£3,073GBP
- Report
- November 2023
- 178 Pages
Global
From €4572EUR$4,900USD£3,862GBP
- Report
- November 2023
- 188 Pages
Global
From €4572EUR$4,900USD£3,862GBP
- Report
- July 2024
- 208 Pages
Global
From €5598EUR$6,000USD£4,729GBP
- Report
- February 2024
- 110 Pages
Global
From €4432EUR$4,750USD£3,744GBP
- Report
- January 2024
- 175 Pages
Global
From €4572EUR$4,900USD£3,862GBP
- Report
- May 2024
- 178 Pages
Global
From €2333EUR$2,500USD£1,970GBP
- Report
- May 2024
- 119 Pages
Global
From €1819EUR$1,950USD£1,537GBP
- Report
- December 2023
- 110 Pages
Global
From €1819EUR$1,950USD£1,537GBP
- Conference
- November 2024
- 2 Days
Global
€979EUR$1,086USD£799GBP
€1224EUR$1,358USD£999GBP
- Report
- May 2024
- 400 Pages
Global
From €3728EUR$3,995USD£3,149GBP
![Loading Indicator](//www.researchandmarkets.com/images/loading.gif)
The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more